Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Cell transplantation/replacement therapy is attractive as a novel strategy for neurological diseases such as Parkinson's disease, Alzheimer's disease, and stroke. To realize this therapy, safer and more therapeutic effective cell resources are now required. Since induced pluripotent stem cells (iPSCs) can retain high replication competence and pluripotency when they differentiate into various kinds of cells, they are regarded as a promising cell source for cell transplantation therapy. However, high tumorigenesis of iPSCs has to be overcome for clinical applications. Recent progress includes the combination of novel transcriptional factors that can convert somatic cells to various kinds of mature neuronal cells and neural stem cells without requiring iPSC fate. Some evidence indicates that these directly induced neuronal cells have little tumorigenic potential. In this article, we discuss the advantage, issues, and possibility of clinical application of these cells for cell transplantation therapy.

Original languageEnglish
Pages (from-to)435-439
Number of pages5
JournalCell Transplantation
Volume23
Issue number4-5
DOIs
Publication statusPublished - 2014

Fingerprint

Cell Transplantation
Cell- and Tissue-Based Therapy
Stem cells
Induced Pluripotent Stem Cells
Neural Stem Cells
Mental Competency
Parkinson Disease
Alzheimer Disease
Carcinogenesis
Therapeutics
Stroke

Keywords

  • Cell transplantation
  • Direct conversion
  • Induced neural stem cells (iNSCs)
  • Induced neuronal cells (iNCs)
  • Induced pluripotent stem cells (iPSCs)

ASJC Scopus subject areas

  • Cell Biology
  • Transplantation
  • Biomedical Engineering
  • Medicine(all)

Cite this

Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy. / Yamashita, Toru; Abe, Koji.

In: Cell Transplantation, Vol. 23, No. 4-5, 2014, p. 435-439.

Research output: Contribution to journalArticle

@article{ed916e608c8743c7a638d150e75e4ac7,
title = "Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy",
abstract = "Cell transplantation/replacement therapy is attractive as a novel strategy for neurological diseases such as Parkinson's disease, Alzheimer's disease, and stroke. To realize this therapy, safer and more therapeutic effective cell resources are now required. Since induced pluripotent stem cells (iPSCs) can retain high replication competence and pluripotency when they differentiate into various kinds of cells, they are regarded as a promising cell source for cell transplantation therapy. However, high tumorigenesis of iPSCs has to be overcome for clinical applications. Recent progress includes the combination of novel transcriptional factors that can convert somatic cells to various kinds of mature neuronal cells and neural stem cells without requiring iPSC fate. Some evidence indicates that these directly induced neuronal cells have little tumorigenic potential. In this article, we discuss the advantage, issues, and possibility of clinical application of these cells for cell transplantation therapy.",
keywords = "Cell transplantation, Direct conversion, Induced neural stem cells (iNSCs), Induced neuronal cells (iNCs), Induced pluripotent stem cells (iPSCs)",
author = "Toru Yamashita and Koji Abe",
year = "2014",
doi = "10.3727/096368914X678274",
language = "English",
volume = "23",
pages = "435--439",
journal = "Cell Transplantation",
issn = "0963-6897",
publisher = "Cognizant Communication Corporation",
number = "4-5",

}

TY - JOUR

T1 - Direct reprogrammed neuronal cells as a novel resource for cell transplantation therapy

AU - Yamashita, Toru

AU - Abe, Koji

PY - 2014

Y1 - 2014

N2 - Cell transplantation/replacement therapy is attractive as a novel strategy for neurological diseases such as Parkinson's disease, Alzheimer's disease, and stroke. To realize this therapy, safer and more therapeutic effective cell resources are now required. Since induced pluripotent stem cells (iPSCs) can retain high replication competence and pluripotency when they differentiate into various kinds of cells, they are regarded as a promising cell source for cell transplantation therapy. However, high tumorigenesis of iPSCs has to be overcome for clinical applications. Recent progress includes the combination of novel transcriptional factors that can convert somatic cells to various kinds of mature neuronal cells and neural stem cells without requiring iPSC fate. Some evidence indicates that these directly induced neuronal cells have little tumorigenic potential. In this article, we discuss the advantage, issues, and possibility of clinical application of these cells for cell transplantation therapy.

AB - Cell transplantation/replacement therapy is attractive as a novel strategy for neurological diseases such as Parkinson's disease, Alzheimer's disease, and stroke. To realize this therapy, safer and more therapeutic effective cell resources are now required. Since induced pluripotent stem cells (iPSCs) can retain high replication competence and pluripotency when they differentiate into various kinds of cells, they are regarded as a promising cell source for cell transplantation therapy. However, high tumorigenesis of iPSCs has to be overcome for clinical applications. Recent progress includes the combination of novel transcriptional factors that can convert somatic cells to various kinds of mature neuronal cells and neural stem cells without requiring iPSC fate. Some evidence indicates that these directly induced neuronal cells have little tumorigenic potential. In this article, we discuss the advantage, issues, and possibility of clinical application of these cells for cell transplantation therapy.

KW - Cell transplantation

KW - Direct conversion

KW - Induced neural stem cells (iNSCs)

KW - Induced neuronal cells (iNCs)

KW - Induced pluripotent stem cells (iPSCs)

UR - http://www.scopus.com/inward/record.url?scp=84900396166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84900396166&partnerID=8YFLogxK

U2 - 10.3727/096368914X678274

DO - 10.3727/096368914X678274

M3 - Article

VL - 23

SP - 435

EP - 439

JO - Cell Transplantation

JF - Cell Transplantation

SN - 0963-6897

IS - 4-5

ER -